GEMINI SPACE STATION INC-A (GEMI) Fundamental Analysis & Valuation

NASDAQ:GEMI • US36866J1051

6.5 USD
-0.1 (-1.52%)
At close: Mar 3, 2026
6.71 USD
+0.21 (+3.23%)
Pre-Market: 3/4/2026, 6:38:02 AM

This GEMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GEMI. GEMI was compared to 238 industry peers in the Capital Markets industry. GEMI may be in some trouble as it scores bad on both profitability and health. GEMI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. GEMI Profitability Analysis

1.1 Basic Checks

  • In the past year GEMI has reported negative net income.
GEMI Yearly Net Income VS EBIT VS OCF VS FCFGEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -20.06%, GEMI is doing worse than 88.24% of the companies in the same industry.
  • The Return On Equity of GEMI (-71.76%) is worse than 87.39% of its industry peers.
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GEMI Yearly ROA, ROE, ROICGEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 100 -100 200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GEMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEMI Yearly Profit, Operating, Gross MarginsGEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 -100 -200 -300

3

2. GEMI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for GEMI remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for GEMI is higher compared to a year ago.
GEMI Yearly Shares OutstandingGEMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
GEMI Yearly Total Debt VS Total AssetsGEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.90, we must say that GEMI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.90, GEMI is doing worse than 86.13% of the companies in the same industry.
  • A Debt/Equity ratio of 0.37 indicates that GEMI is not too dependend on debt financing.
  • The Debt to Equity ratio of GEMI (0.37) is better than 69.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACCN/A
WACCN/A
GEMI Yearly LT Debt VS Equity VS FCFGEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that GEMI should not have too much problems paying its short term obligations.
  • The Current ratio of GEMI (1.29) is comparable to the rest of the industry.
  • A Quick Ratio of 1.29 indicates that GEMI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.29, GEMI is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
GEMI Yearly Current Assets VS Current LiabilitesGEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

3

3. GEMI Growth Analysis

3.1 Past

  • GEMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -306.36%.
  • Looking at the last year, GEMI shows a very strong growth in Revenue. The Revenue has grown by 29.46%.
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%

3.2 Future

  • The Earnings Per Share is expected to decrease by -7.43% on average over the next years.
  • GEMI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 48.22% yearly.
EPS Next Y-337.54%
EPS Next 2Y-42.33%
EPS Next 3Y-7.43%
EPS Next 5YN/A
Revenue Next Year21.21%
Revenue Next 2Y46.7%
Revenue Next 3Y48.22%
Revenue Next 5YN/A

3.3 Evolution

GEMI Yearly Revenue VS EstimatesGEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M
GEMI Yearly EPS VS EstimatesGEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3 -4 -5

0

4. GEMI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GEMI. In the last year negative earnings were reported.
  • Also next year GEMI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEMI Price Earnings VS Forward Price EarningsGEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEMI Per share dataGEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • A cheap valuation may be justified as GEMI's earnings are expected to decrease with -7.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.33%
EPS Next 3Y-7.43%

0

5. GEMI Dividend Analysis

5.1 Amount

  • No dividends for GEMI!.
Industry RankSector Rank
Dividend Yield 0%

GEMI Fundamentals: All Metrics, Ratios and Statistics

GEMINI SPACE STATION INC-A

NASDAQ:GEMI (3/3/2026, 8:15:15 PM)

Premarket: 6.71 +0.21 (+3.23%)

6.5

-0.1 (-1.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-10
Earnings (Next)N/A
Inst Owners31.14%
Inst Owner Change2.97%
Ins Owners7.45%
Ins Owner Change98.94%
Market Cap764.73M
Revenue(TTM)162.53M
Net Income(TTM)-468.98M
Analysts76.25
Price Target15.4 (136.92%)
Short Float %19.1%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-33.19%
PT rev (3m)-44.49%
EPS NQ rev (1m)-11.84%
EPS NQ rev (3m)-30.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-55.92%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-10.62%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.71
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-9.31
EYN/A
EPS(NY)-2.73
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.38
BVpS5.56
TBVpS4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -0.9
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
EPS Next Y-337.54%
EPS Next 2Y-42.33%
EPS Next 3Y-7.43%
EPS Next 5YN/A
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%
Revenue Next Year21.21%
Revenue Next 2Y46.7%
Revenue Next 3Y48.22%
Revenue Next 5YN/A
EBIT growth 1Y2.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-57.5%
EBIT Next 3Y16.67%
EBIT Next 5YN/A
FCF growth 1Y46.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.44%
OCF growth 3YN/A
OCF growth 5YN/A

GEMINI SPACE STATION INC-A / GEMI FAQ

What is the ChartMill fundamental rating of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GEMI.


What is the valuation status of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a valuation rating of 0 / 10 to GEMINI SPACE STATION INC-A (GEMI). This can be considered as Overvalued.


Can you provide the profitability details for GEMINI SPACE STATION INC-A?

GEMINI SPACE STATION INC-A (GEMI) has a profitability rating of 0 / 10.